DEAH-box polypeptide 32 promotes hepatocellular carcinoma progression via activating the β-catenin pathway

CONCLUSION: DHX32 was an attractive regulator of HCC progression and indicated DHX32 canserve as a potential biomarker and therapeutic target for HCC patients.PMID:33729094 | DOI:10.1080/07853890.2021.1898674

Source: Annals of Medicine - March 17, 2021 Category: Internal Medicine Authors: Xiaoyun Hu Guosheng Yuan Qi Li Jing Huang Xiao Cheng Jinzhang Chen Source Type: research